© 2020

Global Pharmaceutical Policy

  • Zaheer-Ud-Din Babar

Table of contents

  1. Front Matter
    Pages i-xviii
  2. Rabia Hussain, Mohamed Azmi Hassali, Zaheer-Ud-Din Babar
    Pages 1-28
  3. Liz Breen, Marina Papalexi, Ying Xie
    Pages 29-52
  4. Mohamed Izham Mohamed Ibrahim, Ahmed Awaisu
    Pages 53-72
  5. Hye-Young Kwon, Yujeong Kim
    Pages 73-97
  6. Iram Malik, Muhammad Atif, Shane L. Scahill, Zaheer-Ud-Din Babar
    Pages 139-175
  7. Daniela Moye-Holz, Anahí Dreser, Octavio Gómez-Dantés, Veronika J. Wirtz
    Pages 177-222
  8. Liliya Eugenevna Ziganshina, Chinara M. Razzakova, Syed Shahzad Hasan, Zaheer-Ud-Din Babar
    Pages 223-246
  9. Grintsova Olga, Zaheer-Ud-Din Babar
    Pages 247-260
  10. Sofia Crisóstomo, Filipa Alves da Costa
    Pages 261-291
  11. Caijun Yang, Amna Saeed, Khezar Hayat, Krizzia-Mae Lambojon, Ali Hassan Gillani, Yu Fang
    Pages 293-308
  12. Suthira Taychakhoonavudh
    Pages 309-330
  13. Mamoon Aldeyab, José-María López-Lozano, Ian M. Gould
    Pages 331-344

About this book


Medicines are vital in improving patient health outcomes and pharmaceutical policy is a fundamental component of any health system. However, the global pharmaceutical policy is ever-evolving and data and quality ‘research-based information’ in this field are scarce. This book fills this gap and provides up-to-date empirical information and evidence-based synthesis. It focuses on pertinent key issues in global pharmaceutical policy including medicines safety, generic medicines, pharmaceutical supply chain, medicines financing, access and affordability of medicines, rational use of medicines, pharmacy health services research and access to vaccines and biological products. Featuring policy case studies from varied countries such as Mexico, Russia, China, Kyrgyzstan, and Pakistan, this book comprises a valuable and comprehensive resource for students, funders, policymakers, academics, and researchers interested in this field.


Pharmaceutical policy counterfeit medicines medicines promotion generic medicines pharmacy health services pharmacoeconomics pharmacovigilance pricing and affordability of medicines Socio-behavioral aspects of health and pharmacy Pharmaceutical promotion Pharmacoeconomics and medicines expenditure Drug pricing and financing Rational drug use

Editors and affiliations

  • Zaheer-Ud-Din Babar
    • 1
  1. 1.Centre for Pharmaceutical Policy and Practice ResearchUniversity of HuddersfieldHuddersfieldUK

About the editors

Zaheer-Ud-Din Babar is Professor in Medicines and Healthcare and the Director of the Centre of Pharmaceutical Policy and Practice Research at the University of Huddersfield, United Kingdom. He has an in-depth understanding of global health, pharmacy systems and pharmaceutical policy and has worked in Malaysia, New Zealand, Pakistan and the UK.

Bibliographic information


“The audience includes students, faculty, researchers, policymakers, and funders interested in pharmaceutical global policy. According to the reviewer, health professionals would also find this book helpful. … No similar book exists that addresses the complexity of access, safety, and medication use. This book presents concise content that illustrate the myriad of factors that impact pharmaceutical policy.” (Carole A. Kenner, Doody's Book Reviews, September 4, 2020)